Back to search
FDAFDA · Food and drugs·Recall number Z-1215-2022

BD Anti-Kappa PE (Cat. No. 346587) is an analyte specific reagent for the Anti-Kappa antibody, which specifically recognizes the kappa light chains of human immunoglobulins. Anti-Kappa is used for in vitro identification of cells expressing the kappa light chains using flow cytometry.

Published June 8, 2022 · Recall initiated: March 25, 2022

Summary

FDA records medical device Class II recall Z-1215-2022, published June 8, 2022 and initiated March 25, 2022. Recalling firm: Becton, Dickinson and Company, BD Biosciences; Status: Ongoing; Reported quantity: 199 units; Lot: Lot # 1228977; UDI: 00382903465873. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Anti-Kappa APC & Anti-Kappa PE analyte reagents may exhibit uncharacteristic flow profiles.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Becton, Dickinson and Company, BD Biosciences
Distributor
Worldwide distribution - US Nationwide distribution in the states of AL, CA, CO, DC, DE, FL, IA, IL, IN, LA, MA, MD, ME, MI, MN, MO, NC, ND, NY, OH, OK, PA, TN, TX, UT, VA, WA, WI, WV and the country of Taiwan.
Lot
Lot # 1228977; UDI: 00382903465873
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was BD Anti-Kappa PE (Cat. No. 346587) is an analyte specific reagent for the Anti-Kappa antibody, which specifically recognizes the kappa light chains of human immunoglobulins. Anti-Kappa is used for in vitro identification of cells expressing the kappa light chains using flow cytometry. recalled?

Yes. FDA published recall Z-1215-2022 on June 8, 2022. Reported hazard: Anti-Kappa APC & Anti-Kappa PE analyte reagents may exhibit uncharacteristic flow profiles.

What should I do if I have this product?

Voluntary: Firm initiated · Letter